Esketamine Augmentation in Treatment-Resistant Obsessive-Compulsive Disorder: A Retrospective Chart Review.

Raíza Alves-PereiraMariana FontesVivian CordeiroIgor D BandeiraDaniela Faria-GuimarãesSamantha S SilvaRodrigo P MelloGustavo C LealAline S SampaioLucas C Quarantini

Published in: Clinical neuropharmacology (2024)

Our findings provide preliminary evidence that esketamine may reduce obsessive-compulsive symptoms in a subset of treatment-resistant OCD patients.

Keyphrases

obsessive compulsive disorder
deep brain stimulation
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis
patient reported outcomes
depressive symptoms
soft tissue